Skip to main content
Top
Published in:

Open Access 16-01-2024 | Editorial

The European Association of Nuclear Medicine (EANM)’s Response to the 2023 European Thyroid Association (ETA) clinical practice guidelines for thyroid nodule management and nuclear medicine: a deliberate oversight?

Authors: Michael C. Kreissl, Petra Petranović Ovčariček, Alfredo Campenni, Alexis Vrachimis, Murat Tuncel, Luca Giovanella

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 6/2024

Login to get access

Excerpt

The European Thyroid Association (ETA) has recently published clinical practice guidelines for thyroid nodule management [1]. This is a promising development aiming towards a streamlined and homogene interdisciplinary approach in the management of thyroid nodules. However, several important aspects of nuclear medicine approaches were not adequately addressed in these guidelines, despite regular exchanges between the EANM and the ETA over the past years. …
Literature
2.
go back to reference Seifert P, Schenke S, Zimny M, Stahl A, Grunert M, Klemenz B, et al. Diagnostic Performance of Kwak, EU, ACR, and Korean TIRADS as Well as ATA Guidelines for the Ultrasound Risk Stratification of Non-Autonomously Functioning Thyroid Nodules in a Region with Long History of Iodine Deficiency: A German Multicenter Trial. Cancers (Basel). 2021 [cited 2023 Oct 25];13:4467. Available from: https://pubmed.ncbi.nlm.nih.gov/34503277/. Seifert P, Schenke S, Zimny M, Stahl A, Grunert M, Klemenz B, et al. Diagnostic Performance of Kwak, EU, ACR, and Korean TIRADS as Well as ATA Guidelines for the Ultrasound Risk Stratification of Non-Autonomously Functioning Thyroid Nodules in a Region with Long History of Iodine Deficiency: A German Multicenter Trial. Cancers (Basel). 2021 [cited 2023 Oct 25];13:4467. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​34503277/​.​
3.
go back to reference Kim DH, Kim SW, Basurrah MA, Lee J, Hwang SH. Diagnostic Performance of Six Ultrasound Risk Stratification Systems for Thyroid Nodules: A Systematic Review and Network Meta-Analysis. AJR Am J Roentgenol. 2023 [cited 2023 Oct 25];220:791–804. Available from: https://pubmed.ncbi.nlm.nih.gov/36752367/. Kim DH, Kim SW, Basurrah MA, Lee J, Hwang SH. Diagnostic Performance of Six Ultrasound Risk Stratification Systems for Thyroid Nodules: A Systematic Review and Network Meta-Analysis. AJR Am J Roentgenol. 2023 [cited 2023 Oct 25];220:791–804. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​36752367/​.​
5.
go back to reference Kuru B, Kefeli M, Danaci M. Comparison of 5 Thyroid Ultrasound Stratification Systems for Differentiation of Benign and Malignant Nodules and to Avoid Biopsy Using Histology as Reference Standard. Endocr Pract. 2021 [cited 2023 Oct 25];27:1093–9. Available from: https://pubmed.ncbi.nlm.nih.gov/33930581/. Kuru B, Kefeli M, Danaci M. Comparison of 5 Thyroid Ultrasound Stratification Systems for Differentiation of Benign and Malignant Nodules and to Avoid Biopsy Using Histology as Reference Standard. Endocr Pract. 2021 [cited 2023 Oct 25];27:1093–9. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​33930581/​.​
6.
go back to reference Grani G, Lamartina L, Ascoli V, Bosco D, Biffoni M, Giacomelli L, et al. Reducing the Number of Unnecessary Thyroid Biopsies While Improving Diagnostic Accuracy: Toward the “Right” TIRADS. J Clin Endocrinol Metab. 2019 [cited 2023 Dec 5];104:95–102. Available from: https://pubmed.ncbi.nlm.nih.gov/30299457/. Grani G, Lamartina L, Ascoli V, Bosco D, Biffoni M, Giacomelli L, et al. Reducing the Number of Unnecessary Thyroid Biopsies While Improving Diagnostic Accuracy: Toward the “Right” TIRADS. J Clin Endocrinol Metab. 2019 [cited 2023 Dec 5];104:95–102. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​30299457/​.​
7.
go back to reference Hoang JK, Asadollahi S, Durante C, Hegedüs L, Papini E, Tessler FN. An International Survey on Utilization of Five Thyroid Nodule Risk Stratification Systems: A Needs Assessment with Future Implications. Thyroid. 2022 [cited 2023 Dec 5];32:675–81. Available from: https://pubmed.ncbi.nlm.nih.gov/35229624/. Hoang JK, Asadollahi S, Durante C, Hegedüs L, Papini E, Tessler FN. An International Survey on Utilization of Five Thyroid Nodule Risk Stratification Systems: A Needs Assessment with Future Implications. Thyroid. 2022 [cited 2023 Dec 5];32:675–81. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​35229624/​.​
8.
go back to reference Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 [cited 2022 Feb 16];26:1–133. Available from: https://pubmed.ncbi.nlm.nih.gov/26462967/. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 [cited 2022 Feb 16];26:1–133. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​26462967/​.​
9.
go back to reference Schenke SA, Kreissl MC, Grunert M, Hach A, Haghghi S, Kandror T, et al. Distribution of Functional Status of Thyroid Nodules and Malignancy Rates of Hyperfunctioning and Hypofunctioning Thyroid Nodules in Germany. Nuklearmedizin. 2022 [cited 2023 Aug 25];61:376–84. Available from: https://pubmed.ncbi.nlm.nih.gov/35917825/. Schenke SA, Kreissl MC, Grunert M, Hach A, Haghghi S, Kandror T, et al. Distribution of Functional Status of Thyroid Nodules and Malignancy Rates of Hyperfunctioning and Hypofunctioning Thyroid Nodules in Germany. Nuklearmedizin. 2022 [cited 2023 Aug 25];61:376–84. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​35917825/​.​
12.
go back to reference Schenke S, Seifert P, Zimny M, Winkens T, Binse I, Görges R. Risk Stratification of Thyroid Nodules Using the Thyroid Imaging Reporting and Data System (TIRADS): The Omission of Thyroid Scintigraphy Increases the Rate of Falsely Suspected Lesions. J Nucl Med. 2019 [cited 2021 Jul 19];60:342–7. Available from: https://jnm.snmjournals.org/content/60/3/342. Schenke S, Seifert P, Zimny M, Winkens T, Binse I, Görges R. Risk Stratification of Thyroid Nodules Using the Thyroid Imaging Reporting and Data System (TIRADS): The Omission of Thyroid Scintigraphy Increases the Rate of Falsely Suspected Lesions. J Nucl Med. 2019 [cited 2021 Jul 19];60:342–7. Available from: https://​jnm.​snmjournals.​org/​content/​60/​3/​342.​
13.
go back to reference Giovanella L, Campenni A, Treglia G, Verburg FA, Trimboli P, Ceriani L, et al. Molecular imaging with (99m)Tc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison. Eur J Nucl Med Mol Imaging. 2016 [cited 2021 Nov 20];43:1018–26. Available from: https://pubmed.ncbi.nlm.nih.gov/26695504/. Giovanella L, Campenni A, Treglia G, Verburg FA, Trimboli P, Ceriani L, et al. Molecular imaging with (99m)Tc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison. Eur J Nucl Med Mol Imaging. 2016 [cited 2021 Nov 20];43:1018–26. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​26695504/​.​
14.
go back to reference Campennì A, Giovanella L, Siracusa M, Alibrandi A, Pignata SA, Giovinazzo S, et al. (99m)Tc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology. Thyroid. 2016 [cited 2021 Nov 20];26:1101–9. Available from: https://pubmed.ncbi.nlm.nih.gov/27266385/. Campennì A, Giovanella L, Siracusa M, Alibrandi A, Pignata SA, Giovinazzo S, et al. (99m)Tc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology. Thyroid. 2016 [cited 2021 Nov 20];26:1101–9. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​27266385/​.​
15.
go back to reference Campennì A, Siracusa M, Ruggeri RM, Laudicella R, Pignata SA, Baldari S, et al. Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: a new quantitative method for improving diagnostic accuracy. Sci Rep. 2017 [cited 2021 Oct 16];7:6147. Available from: https://pubmed.ncbi.nlm.nih.gov/28733644/. Campennì A, Siracusa M, Ruggeri RM, Laudicella R, Pignata SA, Baldari S, et al. Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: a new quantitative method for improving diagnostic accuracy. Sci Rep. 2017 [cited 2021 Oct 16];7:6147. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​28733644/​.
16.
go back to reference Schenke SA, Campennì A, Tuncel M, Bottoni G, Sager S, Crncic TB, et al. Diagnostic Performance of 99mTc-Methoxy-Isobuty-Isonitrile (MIBI) for Risk Stratification of Hypofunctioning Thyroid Nodules: A European Multicenter Study. Diagnostics 2022. 2022 [cited 2023 Oct 23];12:1358. Available from: https://www.mdpi.com/2075-4418/12/6/1358/htm. Schenke SA, Campennì A, Tuncel M, Bottoni G, Sager S, Crncic TB, et al. Diagnostic Performance of 99mTc-Methoxy-Isobuty-Isonitrile (MIBI) for Risk Stratification of Hypofunctioning Thyroid Nodules: A European Multicenter Study. Diagnostics 2022. 2022 [cited 2023 Oct 23];12:1358. Available from: https://​www.​mdpi.​com/​2075-4418/​12/​6/​1358/​htm.​
17.
18.
go back to reference de Koster EJ, de Geus-Oei LF, Brouwers AH, van Dam EWCM, Dijkhorst-Oei LT, van Engen-van Grunsven ACH, et al. [18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial. Eur J Nucl Med Mol Imaging. 2022 [cited 2023 Nov 21];49:1970–84. Available from: https://pubmed.ncbi.nlm.nih.gov/34981165/. de Koster EJ, de Geus-Oei LF, Brouwers AH, van Dam EWCM, Dijkhorst-Oei LT, van Engen-van Grunsven ACH, et al. [18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial. Eur J Nucl Med Mol Imaging. 2022 [cited 2023 Nov 21];49:1970–84. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​34981165/​.​
19.
go back to reference Campennì A, Avram AM, Verburg FA, Iakovou I, Hänscheid H, de Keizer B, et al. The EANM guideline on radioiodine therapy of benign thyroid disease. European Journal of Nuclear Medicine and Molecular Imaging 2023 50:11. 2023 [cited 2023 Oct 2];50:3324–48. Available from: https://link.springer.com/article/https://doi.org/10.1007/s00259-023-06274-5. Campennì A, Avram AM, Verburg FA, Iakovou I, Hänscheid H, de Keizer B, et al. The EANM guideline on radioiodine therapy of benign thyroid disease. European Journal of Nuclear Medicine and Molecular Imaging 2023 50:11. 2023 [cited 2023 Oct 2];50:3324–48. Available from: https://​link.​springer.​com/​article/​https://​doi.​org/​10.​1007/​s00259-023-06274-5.​
20.
21.
go back to reference Bennedbæk FN, Nielsen LK, Hegedüs L. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial. J Clin Endocrinol Metab. 1998 [cited 2023 Nov 21];83:830–5. Available from: https://pubmed.ncbi.nlm.nih.gov/9506736/. Bennedbæk FN, Nielsen LK, Hegedüs L. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial. J Clin Endocrinol Metab. 1998 [cited 2023 Nov 21];83:830–5. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​9506736/​.​
22.
go back to reference Grussendorf M, Reiners C, Paschke R, Wegscheider K. Reduction of thyroid nodule volume by levothyroxine and iodine alone and in combination: a randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2011 [cited 2023 Nov 21];96:2786–95. Available from: https://pubmed.ncbi.nlm.nih.gov/21715542/. Grussendorf M, Reiners C, Paschke R, Wegscheider K. Reduction of thyroid nodule volume by levothyroxine and iodine alone and in combination: a randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2011 [cited 2023 Nov 21];96:2786–95. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​21715542/​.​
23.
go back to reference Graf H, Fast S, Pacini F, Pinchera A, Leung A, Vaisman M, et al. Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study. J Clin Endocrinol Metab. 2011 [cited 2023 Dec 21];96:1368–76. Available from: https://pubmed.ncbi.nlm.nih.gov/21346067/. Graf H, Fast S, Pacini F, Pinchera A, Leung A, Vaisman M, et al. Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study. J Clin Endocrinol Metab. 2011 [cited 2023 Dec 21];96:1368–76. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​21346067/​.​
Metadata
Title
The European Association of Nuclear Medicine (EANM)’s Response to the 2023 European Thyroid Association (ETA) clinical practice guidelines for thyroid nodule management and nuclear medicine: a deliberate oversight?
Authors
Michael C. Kreissl
Petra Petranović Ovčariček
Alfredo Campenni
Alexis Vrachimis
Murat Tuncel
Luca Giovanella
Publication date
16-01-2024
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 6/2024
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-023-06571-z

Other articles of this Issue 6/2024

European Journal of Nuclear Medicine and Molecular Imaging 6/2024 Go to the issue